13F Pro

SEC Form 4 reporting owner

van Houte Hans

van Houte Hans has filed 20 Form 4 transactions reported between January 30, 2026 and August 4, 2026, as Chief Financial Officer of Nurix Therapeutics, Inc..

Name as filed: van Houte Hans

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$516K
8 lines
Companies
1
with Form 4 filings
Latest transaction
Aug 4, 2026
transaction date

Roles and reported holdings

  • NRIXNurix Therapeutics, Inc.
    Jan 30, 2026 – Aug 4, 2026

    Chief Financial Officer

    Held directly40,166 sh as of Aug 4, 2026 · Form 4

    24 months: $516K sold

Transaction history

All 20 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 4, 2026NRIXChief Financial OfficerOpen-market saleCode S · direct2,967$73K@ $24.65Form 4
Aug 4, 2026NRIXChief Financial OfficerOpen-market saleCode S · direct1,794$43K@ $23.89Form 4
Jul 30, 2026NRIXChief Financial OfficerOpen-market saleCode S · direct2,845$67K@ $23.38Form 4
Jul 30, 2026NRIXChief Financial OfficerOption exerciseCode M · direct3,572—Form 4
Jul 30, 2026NRIXChief Financial OfficerOption exerciseCode M · direct2,858—Form 4
Jul 30, 2026NRIXChief Financial OfficerOption exerciseCode M · direct3,750—Form 4
May 5, 2026NRIXChief Financial OfficerOpen-market saleCode S · direct582$10K@ $17.18Form 4
May 5, 2026NRIXChief Financial OfficerOpen-market saleCode S · direct13,473$223K@ $16.58Form 4
Apr 30, 2026NRIXChief Financial OfficerOpen-market saleCode S · direct2,388$40K@ $16.65Form 4
Apr 30, 2026NRIXChief Financial OfficerOption exerciseCode M · direct2,858—Form 4
Apr 30, 2026NRIXChief Financial OfficerOption exerciseCode M · direct3,750—Form 4
Apr 30, 2026NRIXChief Financial OfficerOption exerciseCode M · direct2,000—Form 4
Feb 10, 2026NRIXChief Financial OfficerGrant or awardCode A · direct42,875—Form 4
Feb 10, 2026NRIXChief Financial OfficerGrant or awardCode A · direct93,750—Form 4
Jan 30, 2026NRIXChief Financial OfficerOpen-market saleCode S · direct73$1K@ $17.37Form 4
Jan 30, 2026NRIXChief Financial OfficerOpen-market saleCode S · direct3,588$59K@ $16.58Form 4
Jan 30, 2026NRIXChief Financial OfficerOption exerciseCode M · direct2,859—Form 4
Jan 30, 2026NRIXChief Financial OfficerOption exerciseCode M · direct3,750—Form 4
Jan 30, 2026NRIXChief Financial OfficerOption exerciseCode M · direct2,000—Form 4
Jan 30, 2026NRIXChief Financial OfficerOption exerciseCode M · direct2,887—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.